Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
James Comer to accuse Tim Walz of being...
Expired Obamacare subsidy deal inches toward Senate floor...
JONATHAN TURLEY: Impeachment obsession returns as Democrats recycle...
Rep LaMalfa’s death further shrinks Republican House majority
China bans military-use exports to key US ally...
From sanctions to seizure: What Maduro’s capture means...
Scathing audit reveals more fraud concerns inside top...
Emmer warns Walz could end up ‘in cuffs’...
Trump admin’s new nutrition guidelines target ultra-processed foods,...
Graham warns Iranian ayatollah: ‘Trump is gonna kill...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

‘Both sides are wrong’: Longtime Obamacare critic says GOP is mistaken in shutdown struggle

by admin October 27, 2025
October 27, 2025
‘Both sides are wrong’: Longtime Obamacare critic says GOP is mistaken in shutdown struggle

In the view of Avik Roy — one of the first and most vocal critics of the Affordable Care Act (ACA), also known as Obamacare — Republicans and Democrats alike have missed the mark in the healthcare debate that has dragged the government into a 24-day shutdown.

‘Both sides are wrong,’ Avik said. ‘I’m sympathetic to the Republican view, but it’s a strategic mistake.’

The way Roy sees things, Republican wariness over renewing expanded government subsidies should be directed at the bigger problem behind them.

‘The subsidies aren’t inherently the problem,’ Roy said. ‘If you want low-income people who are near the poverty line to have insurance, you’re going to have to subsidize. Subsidies have been a part of Republican [healthcare] plans and Democratic plans. I would argue that the approach to subsidies that Obamacare used was actually pretty reasonable.’ 

That doesn’t mean he believes the government’s current healthcare trajectory is sustainable, either.

The federal government entered a 24-day shutdown at the beginning of October when lawmakers failed to come to an agreement over spending legislation to begin the new fiscal year. Republicans advanced a short-term spending bill that would have bought more time for lawmakers to finalize funding for 2026. But Democrats, led by Senate Minority Leader Chuck Schumer, D-N.Y., and House Minority Leader Hakeem Jeffries, D-N.Y., have shot down that measure repeatedly, demanding that Congress first address expiring COVID-era insurance subsidies. 

As a part of its American Rescue Plan, the Biden administration greatly widened the pool of eligible applicants who could receive a federal subsidy to help pay for their Obamacare health insurance.

In its original form, Obamacare capped subsidies for anyone making over 400% of the federal poverty level. But that changed in 2021 when, as an emergency response to COVID-19, Congress temporarily removed that cap.

The cap will go back into effect at the end of 2025.

Findings by KFF, a healthcare policy think tank, indicate that over 90% of the 24 million Obamacare enrollees make use of the expanded credits. Letting them expire could leave those Obamacare enrollees suddenly footing a substantially heftier bill. But, according to the Committee of a Responsible Federal Budget, a nonpartisan fiscal policy think tank, continuing the policy would also come with a steep price tag; upwards of $30 billion annually.

Republicans — especially the Hill’s most fiscally conservative lawmakers — have called for the subsidies to expire to help reel the country’s spending back under control.

Despite agreeing with Republicans that Obamacare did little to make health insurance more affordable, Roy believes Republican insistence on letting them expire won’t solve Obamacare’s underlying problems that are driving prices higher: regulations. 

Roy believes Republicans should use the moment to negotiate, extending the subsidies for maybe one to two years for existing enrollees in exchange for a permanent fix of the costliest Obamacare regulations driving costs upward. 

‘In Switzerland [health insurance] costs $200 a month or $300 a month. The same plan in America costs $1,000 a month or $15,000 a month. Subsidizing it also costs a lot. But having a scale where the subsidy fades out gradually as you go up the income scale — that part is fine.’

Roy praised efforts from the Trump administration to bring the underlying costs of healthcare down, most recently through the most favored nation strategy. Under that plan, the Trump administration had leveraged the price other countries pay for pharmaceuticals to bring U.S. prices down.

In theory, the most favored nation plan would set American prices at the lowest rates other countries pay.

‘They’re not actually deals that truly establish most favored nation status because it’s company by company, and they are on particular drugs. But the general idea — if you want to participate in the U.S. market you’ve got to give us the lowest price you give any other advanced economy — I think that’s eminently reasonable,’ Roy said of the administration’s negotiations. 

In response to Democratic demands, Republicans in Congress maintain that the enhanced premium tax credits are completely unrelated to the government’s funding and rejected those demands out of hand.

The Senate has voted on a short-term funding bill 12 times since the beginning of the shutdown and appeared no closer to finding a resolution when the lawmakers left town on Thursday.

The Senate will return to Washington, D.C., at the beginning of next week. 

This post appeared first on FOX NEWS

previous post
Trump courts Japan’s emperor and new PM before high-stakes Xi summit this week
next post
The Tomahawk factor: US long-range missiles are the battlefield gamechanger Putin should fear

You may also like

Vaping advocate warns Dem crackdown on ‘common sense’...

October 12, 2024

GOP wrestles with Obamacare fix as Trump looms...

November 21, 2025

Swalwell demands 2028 Dem candidates vow to destroy...

October 26, 2025

Here is who is vying for power in...

December 10, 2024

Hamas to release 3 more hostages, including US...

February 1, 2025

Mike Johnson says House GOP working full steam...

November 24, 2025

Trump says 80% tariff on China ‘seems right’...

May 10, 2025

Trump signs order instructing DOGE to massively cut...

February 12, 2025

Democrats, left empty-handed in shutdown, turn fury on...

November 11, 2025

JONATHAN TURLEY: Why I’m congratulating the Washington Post

October 26, 2024

Recent Posts

  • James Comer to accuse Tim Walz of being ‘asleep at the wheel’ at fraud hearing
  • Expired Obamacare subsidy deal inches toward Senate floor vote amid bipartisan talks
  • JONATHAN TURLEY: Impeachment obsession returns as Democrats recycle lawfare to fire up their base
  • Rep LaMalfa’s death further shrinks Republican House majority
  • China bans military-use exports to key US ally as Taiwan tensions rise

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (964)
    • Investing (3,814)
    • Politics (4,611)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.